Matches in Wikidata for { <http://www.wikidata.org/entity/Q73062118> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q73062118 description "article scientifique publié en 2000" @default.
- Q73062118 description "artículu científicu espublizáu n'ochobre de 2000" @default.
- Q73062118 description "im Oktober 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73062118 description "scientific article published on 01 October 2000" @default.
- Q73062118 description "wetenschappelijk artikel" @default.
- Q73062118 description "наукова стаття, опублікована в жовтні 2000" @default.
- Q73062118 name "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 name "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 type Item @default.
- Q73062118 label "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 label "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 prefLabel "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 prefLabel "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 P1433 Q73062118-48C60EA0-86FE-4A24-9B27-76072229256E @default.
- Q73062118 P1476 Q73062118-B4E16BB8-2587-4CB1-9292-64469F808946 @default.
- Q73062118 P2093 Q73062118-628C5B71-C350-45E1-895C-18FF6539C5C0 @default.
- Q73062118 P2093 Q73062118-673B1CBD-3E23-4B37-B6AA-6EC158F3C382 @default.
- Q73062118 P2093 Q73062118-BC4E9426-1CC9-4CF5-B6A9-4449B969AECE @default.
- Q73062118 P2093 Q73062118-C1FA066B-D219-43A7-8365-FCBC2F40AF10 @default.
- Q73062118 P2093 Q73062118-C24CA1B0-2F2C-4BCD-81A8-95C767FEAE02 @default.
- Q73062118 P2093 Q73062118-E0182785-85E0-49B9-A75C-C7143EE3B613 @default.
- Q73062118 P2093 Q73062118-FC61AA0F-E3C8-4650-A7A9-44673DFFD86F @default.
- Q73062118 P304 Q73062118-F2A34257-806B-46C2-A5BD-82ED73CBC9CD @default.
- Q73062118 P31 Q73062118-ACDFF66D-8645-4539-A13E-76A5AA16DE2C @default.
- Q73062118 P356 Q73062118-8BED5FC1-D097-49DE-8C51-C411FD214866 @default.
- Q73062118 P433 Q73062118-09CF40F0-0C4D-4F16-902A-C1E1512173F7 @default.
- Q73062118 P478 Q73062118-FF673F86-6C7D-44F3-8783-C3FB3A557CB3 @default.
- Q73062118 P577 Q73062118-B0A751F9-B2F5-490D-94BD-C2E49F7D68DA @default.
- Q73062118 P698 Q73062118-501ABE47-C276-4CBF-B822-D1E1BF1EAA65 @default.
- Q73062118 P921 Q73062118-9CE6A8BD-4DBE-4A61-8F60-BFFA14D95209 @default.
- Q73062118 P921 Q73062118-DDDFA479-8ADC-479C-8962-5DDC679B3C53 @default.
- Q73062118 P356 1096-911X(20001001)35:4%3C403::AID-MPO2%3E3.0.CO;2-M @default.
- Q73062118 P698 11025470 @default.
- Q73062118 P1433 Q15754342 @default.
- Q73062118 P1476 "Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium" @default.
- Q73062118 P2093 "A Gamis" @default.
- Q73062118 P2093 "D Wall" @default.
- Q73062118 P2093 "E S Sandler" @default.
- Q73062118 P2093 "M J Coppes" @default.
- Q73062118 P2093 "M M Mustafa" @default.
- Q73062118 P2093 "N Kamani" @default.
- Q73062118 P2093 "R Hagg" @default.
- Q73062118 P304 "403-409" @default.
- Q73062118 P31 Q13442814 @default.
- Q73062118 P356 "10.1002/1096-911X(20001001)35:4<403::AID-MPO2>3.0.CO;2-M" @default.
- Q73062118 P433 "4" @default.
- Q73062118 P478 "35" @default.
- Q73062118 P577 "2000-10-01T00:00:00Z" @default.
- Q73062118 P698 "11025470" @default.
- Q73062118 P921 Q418817 @default.
- Q73062118 P921 Q65592366 @default.